Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001641172-25-021034
Filing Date
2025-07-25
Accepted
2025-07-25 16:50:19
Documents
6
Period of Report
2025-07-25

Document Format Files

Seq Description Document Type Size
1 PRE 14A formpre14a.htm PRE 14A 505080
2 GRAPHIC formpre14a_001.jpg GRAPHIC 3009
3 GRAPHIC formpre14a_002.jpg GRAPHIC 2962
4 GRAPHIC formpre14a_003.jpg GRAPHIC 4364
5 GRAPHIC proxy_001.jpg GRAPHIC 1463184
6 GRAPHIC proxy_002.jpg GRAPHIC 970917
  Complete submission text file 0001641172-25-021034.txt   3869399
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40943 | Film No.: 251152201
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)